Remy Sukhija's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 15,001 Common Stock done . Disclosure was reported to the exchange on Jan. 16, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 15,001 | 15,001 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.26 per share. | 23 Dec 2022 | 30,000 | 30,000 (0%) | 0% | 60.3 | 1,807,800 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 272.68 per share. | 23 Dec 2022 | 5,534 | 15,224 (0%) | 0% | 272.7 | 1,509,011 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 274.56 per share. | 23 Dec 2022 | 3,019 | 9,734 (0%) | 0% | 274.6 | 828,897 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 279.15 per share. | 23 Dec 2022 | 3,003 | 4,520 (0%) | 0% | 279.1 | 838,287 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 279.96 per share. | 23 Dec 2022 | 2,620 | 1,900 (0%) | 0% | 280.0 | 733,495 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 273.54 per share. | 23 Dec 2022 | 2,471 | 12,753 (0%) | 0% | 273.5 | 675,917 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 271.54 per share. | 23 Dec 2022 | 2,084 | 20,758 (0%) | 0% | 271.5 | 565,889 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 270.56 per share. | 23 Dec 2022 | 2,069 | 22,842 (0%) | 0% | 270.6 | 559,789 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 268.50 per share. | 23 Dec 2022 | 1,913 | 26,387 (0%) | 0% | 268.5 | 513,641 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 269.61 per share. | 23 Dec 2022 | 1,476 | 24,911 (0%) | 0% | 269.6 | 397,944 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 267.47 per share. | 23 Dec 2022 | 1,107 | 28,300 (0%) | 0% | 267.5 | 296,089 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 280.92 per share. | 23 Dec 2022 | 1,000 | 900 (0%) | 0% | 280.9 | 280,920 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 275.70 per share. | 23 Dec 2022 | 811 | 8,923 (0%) | 0% | 275.7 | 223,593 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 276.67 per share. | 23 Dec 2022 | 700 | 8,223 (0%) | 0% | 276.7 | 193,669 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 277.83 per share. | 23 Dec 2022 | 700 | 7,523 (0%) | 0% | 277.8 | 194,481 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 266.04 per share. | 23 Dec 2022 | 593 | 29,407 (0%) | 0% | 266.0 | 157,762 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 282.13 per share. | 23 Dec 2022 | 400 | 500 (0%) | 0% | 282.1 | 112,852 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 283.43 per share. | 23 Dec 2022 | 400 | 100 (0%) | 0% | 283.4 | 113,372 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 284.65 per share. | 23 Dec 2022 | 100 | 0 (0%) | 0% | 284.7 | 28,465 | Common Stock |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Madrigal Pharmaceuticals Inc | Remy Sukhija | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) |